Last Posted: Feb 21, 2019
- Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen Pertti et al. ESC heart failure 2019 Feb - Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristics.
Vischer Annina S et al. International journal of cardiology 2019 Jan - Impact of NBS for VLCAD deficiency on genetic, enzymatic and clinical outcomes.
Bleeker Jeannette C et al. Journal of inherited metabolic disease 2019 Feb - Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
Aljeaid Deema et al. American journal of medical genetics. Part A 2019 Feb - Awareness of Fabry disease in cardiology: A gap to be filled.
Brito Dulce et al. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2018 37(6) 457-466 - Fabry disease: Review and experience during newborn screening.
Hsu Ting-Rong et al. Trends in cardiovascular medicine 2018 28(4) 274-281 - Fatty acid oxidation disorders.
Merritt J Lawrence et al. Annals of translational medicine 2018 Dec 6(24) 473 - Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation.
Khayata Mohamed et al. World journal of cardiology 2019 Jan 11(1) 38-46 - Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles Jodie et al. Circulation. Genomic and precision medicine 2019 Jan - Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.
Walsh Roddy et al. Genome medicine 2019 Jan 11(1) 5
.png)
No hay comentarios:
Publicar un comentario